Apitegromab

Synonyms: 阿匹特古单抗; SRK-015
Apitegromab (SRK-015) 是一种抗肌生长抑制素单克隆抗体,可用于包括脊髓性肌萎缩症在内的神经肌肉疾病的研究。
产品编号: MS-V36699 纯度: 99.51% CAS No.: 2278276-46-1
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
1mg
询价
3-5 天
5mg
询价
3-5 天
10mg
询价
询价
25mg
询价
询价
50mg
询价
询价
100mg
询价
询价
200mg
询价
询价

产品描述

Apitegromab (SRK-015) 是一种抗肌生长抑制素单克隆抗体,可用于包括脊髓性肌萎缩症在内的神经肌肉疾病的研究。

生物实验数据

生物活性 Apitegromab (SRK-015) is an anti-myostatin monoclonal antibody that can be used for research on neuromuscular diseases, including spinal muscular atrophy.
IC50 & Target

GDF8/Myostatin

体外研究
(In Vitro)

Apitegromab (IC50:人 286 nM,食蟹猴 626 nM,大鼠 178 nM,16 小时) 有效抑制促肌肉生长抑制素的活化,并表现出物种依赖性的效力差异。

体内研究
(In Vivo)

Apitegromab (10-300 mg/kg, 静脉注射,一周一次,共 4、7 或 26 周) 在幼年和成年 Sprague Dawley 大鼠以及成年食蟹猴中耐受性良好,未见严重毒性反应。

Animal Model: Adult cynomolgus monkeys (32-48 months)
Dosage: 10, 30, 100 mg/kg
Administration: Intravenous bolus (IV bolus), once weekly for 4 weeks
Result: Did not cause treatment-related adverse effects, increased gastrocnemius and biceps brachii mass (5-25%), but did not exhibit dose dependency, and did not lead to significant histopathological changes or cardiac electrophysiological abnormalities.
Animal Model: Sprague Dawley rats: adult group (6-8 weeks) or juvenile group (postnatal day 21)
Dosage: 10, 30, 100, 300 mg/kg
Administration: Intravenous bolus (IV bolus), once weekly for 4 weeks (adult group), 7 weeks (juvenile group) or 26 weeks (adult group)
Result: Increased body weight independently of food intake, enhanced skeletal muscle mass (biceps brachii and gastrocnemius) by 3-32%, and caused minor clinical chemistry changes (mild increase in total protein and globulin), which were mostly reversible (adult group, administration for 4 weeks).
increased muscle mass by 15-33%, induced mild muscle fiber hypertrophy (histological analysis), and caused minor hematological changes without significant toxicity; it did not produce adverse effects on cardiovascular, neurological, or reproductive systems (adult group, administration for 26 weeks).
increased body weight (significant in females) without impacting growth and development, enhanced skeletal muscle mass (biceps brachii and gastrocnemius) by 13-28%, and did not cause neurobehavioral abnormalities (acoustic startle, locomotor activity, Morris water maze); it had no effects on sperm quality or fertility, indicating normal reproductive function (juvenile group).
Clinical Trial
NCT NumberSponsorConditionStart DatePhase
NCT07435129Scholar Rock, Inc.
Facioscapulohumeral Muscular Dystrophy|FSHD
2026-08PHASE2
NCT06445075Scholar Rock, Inc.
Overweight and Obesity
2024-05-21PHASE2
NCT07047144Scholar Rock, Inc.
Spinal Muscular Atrophy|SMA|Spinal Muscular Atrophy Type 2|Spinal Muscular Atrophy Type 3|Neuromuscular Manifestations|Anti-myostatin
2025-09-15PHASE2
性状 液体
颜色 Colorless to light yellow

化学信息

CAS No. 2278276-46-1
别名 阿匹特古单抗; SRK-015

储存&溶解度

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

运输条件 Shipping with dry ice.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础